glp-1 food industry impact news today Ozempic Could Crush the Junk Industry. But It Is Fighting Back GLP-1 Trends: Lifestyle Changes, Dining

13,14 Intriguingly, emerging research proposes that GLP-1 RA treatments might hold the potential to treat addictive disorders, although this area remains under investigation

Boehringer Ingelheim, in collaboration with Zealand Pharma, will likely be the next big challenger after advancing its promising candidate survodutide, a GCGR/GLP-1R dual agonist, to Phase 3 clinical trials last year

When you have a classic UTI, your symptoms cant tell you what it is thats causing it, he says

Confirm the current status of FDA's June 2026 503B bulks list proposal and what it means for your program's pharmacy and medication source - verify at FDA.gov before your first billing cycle